AIM 8-K 2026-09-04

AIM ImmunoTech Inc. (AIM) 8-K dated 2026-09-04 — accession 0001493152-26-041537. This URL is the filing, not the AIM hub.

AIM ImmunoTech Inc. (AIM) common stock.

AIM ImmunoTech Inc. filed a 8-K on 2026-09-04. Accession 0001493152-26-041537.

Cached items: 1.01, 1.02, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AIM revenue for 2025-12-31 was $88.0K. Net income was -$14.0M. Revenue was down 48.2% from 2024-12-31 to 2025-12-31. AIM currently screens at market cap $0.

Not investment advice. The AIM SEC hub lists recent forms. The stock page is the research view.